Explanation of the “Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma”

Explanation of the “Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma”

Bibliographic Details
Main Author:	DONG Jing
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2014-07-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatitis B; hepatitis C; carcinoma hepatocellular; therapy; guidebooks
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=5949&ClassID=71494231

Similar Items

Explanation of the “Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma”
by: DONG Jing
Published: (2013-01-01)

Recommendation on antiviral therapy to hepatitis B/C virus related hepatocellular carcinoma
by: Liver Cancer Study Group，Chinese Society of Hepatology，Chinese Medical Association
Published: (2013-01-01)

Expert consenus on antiviral therapy for special patients with chronic hepatitis B: an update in 2014
by: Committee of experts on antiviral therapy for special patients with chronic hepatitis B
Published: (2014-07-01)

Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
by: Jonggi Choi, et al.
Published: (2021-04-01)

Hepatocellular carcinoma in hepatitis D: Does it differ from hepatitis B monoinfection?
by: Zaigham Abbas, et al.
Published: (2012-01-01)

Expert consensus on clinical management of adverse reactions in interferon-α therapy for chronic viral hepatitis
by: Expert Committee on Clinical Management of Adverse Reactions in Interferon-α Therapy for Chronic Viral Hepatitis
Published: (2014-11-01)

Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
by: Hiotis Spiros P, et al.
Published: (2012-06-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Catana, A.M, et al.
Published: (2022)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01)

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study
by: Yu‐Chi Lee, et al.
Published: (2021-10-01)

Expert interpretation of the “KASL Clinical Practice Guidelines: Management of hepatitis C”
by: DING Yang
Published: (2015-01-01)

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
by: Ming-Tsung Lin, et al.
Published: (2021-01-01)

Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo
by: Patrícia Lofêgo Gonçalves, et al.
Published: (2014-10-01)

Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
by: D T Abdurakhmanov
Published: (2013-10-01)

Clinical, Pathological and Genetic Characteristics of Pediatric Hepatocellular Carcinoma Associated with Hepatitis B Virus Infection
by: Zhao P, et al.
Published: (2021-05-01)

Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma
by: Xiu-Tao Fu, et al.
Published: (2017-05-01)

Analysis of quality of life and prognosis in patients with HBV-related end-stage hepatocellular carcinoma after antiviral therapy
by: LI Peng
Published: (2015-05-01)

Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
by: R.S.M. Alencar, et al.
Published: (2008-03-01)

Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study
by: Maria Makarova, et al.
Published: (2013-05-01)

Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence
by: Jing Jin, et al.
Published: (2016-05-01)

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study
by: Zhang Y, et al.
Published: (2018-03-01)

Hepatitis C virus-induced hepatocellular carcinoma
by: Nicolas Goossens, et al.
Published: (2015-06-01)

Glucose-regulated protein 78 demonstrates antiviral effects but is more suitable for hepatocellular carcinoma prevention in hepatitis B
by: Nai Q. Zheng, et al.
Published: (2017-04-01)

Hepatocellular carcinoma in a woman with 34 weeks gestation and chronic hepatitis b
by: Sato-Espinoza, Karina, et al.
Published: (2021)

Association between hepatitis C and hepatocellular carcinoma
by: Luis Jesuino de Oliveira Andrade, et al.
Published: (2009-01-01)

Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
by: Hyun Woong Lee
Published: (2019-11-01)

Hepatocellular carcinoma with vertebral metastasis in a child with hepatitis B virus infection: a case report
by: Tinsae Alemayehu, et al.
Published: (2019-05-01)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
by: Xiaofei Li, et al.
Published: (2020-04-01)

The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
by: Chen X, et al.
Published: (2017-11-01)

Elevated Perioperative Transaminase Level Predicts Intrahepatic Recurrence in Hepatitis B-related Hepatocellular Carcinoma After Curative Hepatectomy
by: Yue-Sun Cheung, et al.
Published: (2008-04-01)

Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma
by: So Jung Lee, et al.
Published: (2012-09-01)

Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma
by: Sara Naimimohasses, et al.
Published: (2017-12-01)

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
by: Li Bin, et al.
Published: (2011-09-01)

Hepatitis B virus related hepatocellular carcinoma is the predominant cause of liver cancer in Bangladesh
by: Md. Fazal Karim, et al.
Published: (2012-01-01)

H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection
by: Chang, C.-C, et al.
Published: (2022)

Original Article. Hepatitis B Virus S Promoter Deletion in Hepatocellular Carcinoma
by: Jiang Su-zhen, et al.
Published: (2012-03-01)

Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C
by: Qin Wei, et al.
Published: (2017-11-01)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
by: Xinhe Zhang, et al.
Published: (2021-09-01)

Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
by: Ho Soo Chun, et al.
Published: (2021-07-01)

Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
by: Xiaofei Li, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_ghe90q5jqcm4gnsivpph3rdu7k